Cargando…
Medicaid expansion and drug overdose mortality during the COVID-19 pandemic in the United States
BACKGROUND: The COVID-19 pandemic caused disruptions in the delivery of health services, which may have adversely affected access to substance use disorder (SUD) treatment services. Medicaid expansion has been previously associated with increased access to SUD services for low-income adults. Thus, t...
Autores principales: | Auty, Samantha G., Griffith, Kevin N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8809643/ https://www.ncbi.nlm.nih.gov/pubmed/35131533 http://dx.doi.org/10.1016/j.drugalcdep.2022.109340 |
Ejemplares similares
-
Association of Medicaid Expansion With Opioid Overdose Mortality in the United States
por: Kravitz-Wirtz, Nicole, et al.
Publicado: (2020) -
Applying Farr’s Law to project the drug overdose mortality epidemic in the United States
por: Darakjy, Salima, et al.
Publicado: (2014) -
Medicaid expansion and opioid supply policies to address the opioid overdose crisis
por: Shakya, Shishir, et al.
Publicado: (2022) -
Growing racial/ethnic disparities in overdose mortality before and during the COVID-19 pandemic in California
por: Friedman, Joseph, et al.
Publicado: (2021) -
Economic burden of drug overdose deaths before and during the COVID-19 pandemic in the USA
por: Lui, Briana, et al.
Publicado: (2022)